These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11570411)

  • 1. Tubal ligation and risk of ovarian cancer.
    Piek JM; van Diest PJ; Zweemer RP; Kenemans P; Verheijen RH
    Lancet; 2001 Sep; 358(9284):844. PubMed ID: 11570411
    [No Abstract]   [Full Text] [Related]  

  • 2. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
    Piek JM; Verheijen RH; van Diest PJ
    Histopathology; 2009 Mar; 54(4):494-5. PubMed ID: 19309405
    [No Abstract]   [Full Text] [Related]  

  • 3. The fallopian tube: primary site of most pelvic high-grade serous carcinomas.
    Salvador S; Gilks B; Köbel M; Huntsman D; Rosen B; Miller D
    Int J Gynecol Cancer; 2009 Jan; 19(1):58-64. PubMed ID: 19258943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary epithelioma of the fallopian tube. Cytological screening].
    Liégeois A
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):745-53. PubMed ID: 4661777
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenocarcinoma of the bilateral fallopian tube occurring after tubal sterilization.
    Toki T; Imai T; Kobayashi H; Oguchi O; Silverberg SG; Fujii S
    Gynecol Oncol; 1995 Sep; 58(3):400-3. PubMed ID: 7672711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/2-related ovarian cancers are of tubal origin: a hypothesis.
    Piek JM; Verheijen RH; Kenemans P; Massuger LF; Bulten H; van Diest PJ
    Gynecol Oncol; 2003 Aug; 90(2):491. PubMed ID: 12893227
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgical implications of the potential new tubal pathway for ovarian carcinogenesis.
    Chene G; Rahimi K; Mes-Masson AM; Provencher D
    J Minim Invasive Gynecol; 2013; 20(2):153-9. PubMed ID: 23332575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary adenocarcinoma of the fallopian tube--a case report.
    Tharmaseelan NK; Sundralingam S
    Med J Malaysia; 1989 Dec; 44(4):354-6. PubMed ID: 2520049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.
    Jarboe EA; Folkins AK; Drapkin R; Ince TA; Agoston ES; Crum CP
    Histopathology; 2009 Nov; 55(5):619. PubMed ID: 19912369
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary adenocarcinoma of fallopian tube--a case report.
    Kalyani R; Kumar ML; Srikantia SH
    Indian J Pathol Microbiol; 2005 Apr; 48(2):219-21. PubMed ID: 16758673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary carcinoma of the Fallopian tube. Report of 3 clinical cases].
    Andrade Vargas A; Casasola García J; Nahamad Serranía M; Moreno Bonet H; Alonso Muñóz G
    Ginecol Obstet Mex; 1979 Apr; 45(270):299-309. PubMed ID: 456923
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary adenocarcinoma of the fallopian tube. A case report with discussion of its pattern of endometrial spread and possible resulting diagnostic confusion.
    Tjiptohardjo TA; Gisser SD
    Diagn Gynecol Obstet; 1981; 3(1):45-8. PubMed ID: 7215123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer.
    Manchanda R; Drapkin R; Jacobs I; Menon U
    Gynecol Oncol; 2012 Feb; 124(2):185-91. PubMed ID: 22019526
    [No Abstract]   [Full Text] [Related]  

  • 15. Heat artifact simulating adenocarcinoma of fallopian tube.
    Cornog JL; Currie JL; Rubin A
    JAMA; 1970 Nov; 214(6):1118-9. PubMed ID: 5536255
    [No Abstract]   [Full Text] [Related]  

  • 16. Adnexal malignancy detected by cervical cytology.
    Fox CH
    Am J Obstet Gynecol; 1978 Sep; 132(2):148-50. PubMed ID: 686103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
    BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distal fallopian tube: a new model for pelvic serous carcinogenesis.
    Crum CP; Drapkin R; Miron A; Ince TA; Muto M; Kindelberger DW; Lee Y
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):3-9. PubMed ID: 17218844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
    Cass I; Walts A; Karlan BY
    Gynecol Oncol; 2010 Apr; 117(1):27-31. PubMed ID: 20110118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary invasive adenocarcinoma of the fallopian tube diagnosed by histological examination of a surgical sterilization specimen. Case report.
    Nordin AJ; Richardson JA; Smith SC
    Eur J Gynaecol Oncol; 1993; 14(6):466-8. PubMed ID: 8181485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.